|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Alnylam Pharmaceuticals (NASDAQ: ALNY) through any online brokerage.
The latest price target for Alnylam Pharmaceuticals (NASDAQ: ALNY) was reported by Morgan Stanley on October 12, 2021. The analyst firm set a price target for 242.00 expecting ALNY to rise to within 12 months (a possible 21.85% upside). 20 analyst firms have reported ratings in the last year.
The stock price for Alnylam Pharmaceuticals (NASDAQ: ALNY) is $198.61 last updated Fri Oct 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Alnylam Pharmaceuticals.
Alnylam Pharmaceuticals’s $Q3 earnings are confirmed for after-market on $October 28, 2021.
There is no upcoming split for Alnylam Pharmaceuticals.
Alnylam Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.